Profiel
Jane Wang is currently the Chief Scientific Officer at Apollomics, Inc. (United States).
Previously, she worked as a Principal at Pfizer Inc. and as the Vice President-Medicinal Chemistry at WuXi AppTec Co., Ltd. from 2010 to 2022.
She also served as the Chief Scientific Officer at Apollomics, Inc. from 2023 to 2024.
Dr. Wang holds a doctorate degree from the University of Maryland and an undergraduate degree from Fudan University.
Actieve functies van Jane Wang
| Bedrijven | Functie | Begin |
|---|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops targeted oncology drugs and immunotherapies | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Jane Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| APOLLOMICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2024 |
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01-07-2022 |
| PFIZER INC. | Corporate Officer/Principal | - |
Opleiding van Jane Wang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products & medical devices | Health Technology |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops targeted oncology drugs and immunotherapies | Health Technology |
Apollomics, Inc.
Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients | Finance |
















